Chemotherapy for cancer patients who present late.

about

What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: qualitative study.Treatment options in end-of-life care: the role of palliative chemotherapy.Ultrasound: a chemotherapy sensitizer.

P2860

Q36802690-641430D1-704D-4C22-8FAF-C90FF9BCB02F Q37029886-D8E98007-592D-4740-8660-8E170824E82E Q46897351-BC8AA975-705C-49C4-ACD8-7E27424E25AD

P2860

Chemotherapy for cancer patients who present late.

Item

http://www.wikidata.org/entity/Q35802013

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Chemotherapy for cancer patients who present late.

@ast

Chemotherapy for cancer patients who present late.

@en

type

Item

label

Chemotherapy for cancer patients who present late.

@ast

Chemotherapy for cancer patients who present late.

@en

prefLabel

Chemotherapy for cancer patients who present late.

@ast

Chemotherapy for cancer patients who present late.

@en

P1476

Chemotherapy for cancer patients who present late.

@en

P2093

Charles D Shee

http://www.w3.org/2001/XMLSchema#string

Peter G Harper

http://www.w3.org/2001/XMLSchema#string

Saad M B Rassam

http://www.w3.org/2001/XMLSchema#string

Stella J Bowcock

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy versus best supportive care for extensive small cell lung cancer

Palliative chemotherapy: no longer a contradiction in terms.

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews.

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors.

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.

The role of chemotherapy in the hospice patient. A problem of definition.

The treatment of acute leukaemia.

P304

1430-1432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.328.7453.1430

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

7453

http://www.w3.org/2001/XMLSchema#string

P478

328

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8515415

http://www.w3.org/2001/XMLSchema#string

P698

15191983

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

421791

http://www.w3.org/2001/XMLSchema#string

Chemotherapy for cancer patients who present late.

about

P2860

P2860

Chemotherapy for cancer patients who present late.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932